APO Research
Talk to an analyst

APO RESEARCH · REPORT

γ-Aminobutyric Acid Receptor Agonists

Compare research editions
View pricing & licenses

Selected research

Industry Research

γ-Aminobutyric Acid Receptor Agonists Industry Research Report 2026

20 December 2025143 pages

Choose your research edition.

Industry Researchγ-Aminobutyric Acid Receptor Agonists Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal γ-Aminobutyric Acid Receptor Agonists Industry Growth and Trends Forecast to 2032128 pages · $3,450 USDMarket StructureGlobal γ-Aminobutyric Acid Receptor Agonists Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal γ-Aminobutyric Acid Receptor Agonists Market Outlook and Growth Opportunities 2026219 pages · $4,250 USDMarket Analysis & ForecastGlobal γ-Aminobutyric Acid Receptor Agonists Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global γ-Aminobutyric Acid Receptor Agonists market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for γ-Aminobutyric Acid Receptor Agonists is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for γ-Aminobutyric Acid Receptor Agonists is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for γ-Aminobutyric Acid Receptor Agonists is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of γ-Aminobutyric Acid Receptor Agonists include Akorn, Apotex, CHEPLAPHARM, Hikma, Jazz Pharmaceuicals, Neurelis, SAGE Therapeutics, Sandoz and Torrent Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global γ-Aminobutyric Acid Receptor Agonists market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

γ-Aminobutyric Acid Receptor Agonists Market by Company

Akorn

Apotex

CHEPLAPHARM

Hikma

Jazz Pharmaceuicals

Neurelis

SAGE Therapeutics

Sandoz

Torrent Pharma

Viatris

WG Critical Care

AstraZeneca

Changzhou Siyao Pharmaceutical

Fresenius Kabi

GSK

Sichuan HaiscoPharmaceuical

Huazhong Pharmaceutical

Pfizer

Roche

Mylan

Novartis

Sanofi

Shanghai Pharmaceuticals Holding

Sun Pharma

Teva

Takeda

γ-Aminobutyric Acid Receptor Agonists Segment by Type

GABAA Receptors

GABAB Receptors

GABAC Receptors

γ-Aminobutyric Acid Receptor Agonists Segment by Application

Epilepsy

Anxiety

Neuropathic Pain

Insomnia

Other

γ-Aminobutyric Acid Receptor Agonists Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global γ-Aminobutyric Acid Receptor Agonists market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of γ-Aminobutyric Acid Receptor Agonists and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of γ-Aminobutyric Acid Receptor Agonists.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of γ-Aminobutyric Acid Receptor Agonists manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of γ-Aminobutyric Acid Receptor Agonists by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of γ-Aminobutyric Acid Receptor Agonists in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global γ-Aminobutyric Acid Receptor Agonists Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global γ-Aminobutyric Acid Receptor Agonists Sales (K Units) of Manufacturers (2021-2026) Table 7. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Manufacturers (2021-2026) Table 8. Global γ-Aminobutyric Acid Receptor Agonists Revenue of Manufacturers (2021-2026) Table 9. Global γ-Aminobutyric Acid Receptor Agonists Revenue Share by Manufacturers (2021-2026) Table 10. Global Market γ-Aminobutyric Acid Receptor Agonists Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global γ-Aminobutyric Acid Receptor Agonists Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of γ-Aminobutyric Acid Receptor Agonists, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of γ-Aminobutyric Acid Receptor Agonists, Product Type & Application Table 14. Global γ-Aminobutyric Acid Receptor Agonists Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global γ-Aminobutyric Acid Receptor Agonists by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Akorn Company Information Table 19. Akorn Business Overview Table 20. Akorn γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Akorn γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 22. Akorn Recent Developments Table 23. Apotex Company Information Table 24. Apotex Business Overview Table 25. Apotex γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Apotex γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 27. Apotex Recent Developments Table 28. CHEPLAPHARM Company Information Table 29. CHEPLAPHARM Business Overview Table 30. CHEPLAPHARM γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. CHEPLAPHARM γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 32. CHEPLAPHARM Recent Developments Table 33. Hikma Company Information Table 34. Hikma Business Overview Table 35. Hikma γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Hikma γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 37. Hikma Recent Developments Table 38. Jazz Pharmaceuicals Company Information Table 39. Jazz Pharmaceuicals Business Overview Table 40. Jazz Pharmaceuicals γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Jazz Pharmaceuicals γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 42. Jazz Pharmaceuicals Recent Developments Table 43. Neurelis Company Information Table 44. Neurelis Business Overview Table 45. Neurelis γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Neurelis γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 47. Neurelis Recent Developments Table 48. SAGE Therapeutics Company Information Table 49. SAGE Therapeutics Business Overview Table 50. SAGE Therapeutics γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. SAGE Therapeutics γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 52. SAGE Therapeutics Recent Developments Table 53. Sandoz Company Information Table 54. Sandoz Business Overview Table 55. Sandoz γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Sandoz γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 57. Sandoz Recent Developments Table 58. Torrent Pharma Company Information Table 59. Torrent Pharma Business Overview Table 60. Torrent Pharma γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Torrent Pharma γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 62. Torrent Pharma Recent Developments Table 63. Viatris Company Information Table 64. Viatris Business Overview Table 65. Viatris γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Viatris γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 67. Viatris Recent Developments Table 68. WG Critical Care Company Information Table 69. WG Critical Care Business Overview Table 70. WG Critical Care γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. WG Critical Care γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 72. WG Critical Care Recent Developments Table 73. AstraZeneca Company Information Table 74. AstraZeneca Business Overview Table 75. AstraZeneca γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. AstraZeneca γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 77. AstraZeneca Recent Developments Table 78. Changzhou Siyao Pharmaceutical Company Information Table 79. Changzhou Siyao Pharmaceutical Business Overview Table 80. Changzhou Siyao Pharmaceutical γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Changzhou Siyao Pharmaceutical γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 82. Changzhou Siyao Pharmaceutical Recent Developments Table 83. Fresenius Kabi Company Information Table 84. Fresenius Kabi Business Overview Table 85. Fresenius Kabi γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Fresenius Kabi γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 87. Fresenius Kabi Recent Developments Table 88. GSK Company Information Table 89. GSK Business Overview Table 90. GSK γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. GSK γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 92. GSK Recent Developments Table 93. Sichuan HaiscoPharmaceuical Company Information Table 94. Sichuan HaiscoPharmaceuical Business Overview Table 95. Sichuan HaiscoPharmaceuical γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Sichuan HaiscoPharmaceuical γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 97. Sichuan HaiscoPharmaceuical Recent Developments Table 98. Huazhong Pharmaceutical Company Information Table 99. Huazhong Pharmaceutical Business Overview Table 100. Huazhong Pharmaceutical γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Huazhong Pharmaceutical γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 102. Huazhong Pharmaceutical Recent Developments Table 103. Pfizer Company Information Table 104. Pfizer Business Overview Table 105. Pfizer γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Pfizer γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 107. Pfizer Recent Developments Table 108. Roche Company Information Table 109. Roche Business Overview Table 110. Roche γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Roche γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 112. Roche Recent Developments Table 113. Mylan Company Information Table 114. Mylan Business Overview Table 115. Mylan γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Mylan γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 117. Mylan Recent Developments Table 118. Novartis Company Information Table 119. Novartis Business Overview Table 120. Novartis γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Novartis γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 122. Novartis Recent Developments Table 123. Sanofi Company Information Table 124. Sanofi Business Overview Table 125. Sanofi γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Sanofi γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 127. Sanofi Recent Developments Table 128. Shanghai Pharmaceuticals Holding Company Information Table 129. Shanghai Pharmaceuticals Holding Business Overview Table 130. Shanghai Pharmaceuticals Holding γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Shanghai Pharmaceuticals Holding γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 132. Shanghai Pharmaceuticals Holding Recent Developments Table 133. Sun Pharma Company Information Table 134. Sun Pharma Business Overview Table 135. Sun Pharma γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Sun Pharma γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 137. Sun Pharma Recent Developments Table 138. Teva Company Information Table 139. Teva Business Overview Table 140. Teva γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Teva γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 142. Teva Recent Developments Table 143. Takeda Company Information Table 144. Takeda Business Overview Table 145. Takeda γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. Takeda γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 147. Takeda Recent Developments Table 148. Global γ-Aminobutyric Acid Receptor Agonists Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 149. Global γ-Aminobutyric Acid Receptor Agonists Sales by Region (2021-2026) & (K Units) Table 150. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Region (2021-2026) Table 151. Global γ-Aminobutyric Acid Receptor Agonists Sales by Region (2027-2032) & (K Units) Table 152. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Region (2027-2032) Table 153. Global γ-Aminobutyric Acid Receptor Agonists Revenue by Region (2021-2026) & (US$ Million) Table 154. Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Region (2021-2026) Table 155. Global γ-Aminobutyric Acid Receptor Agonists Revenue by Region (2027-2032) & (US$ Million) Table 156. Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Region (2027-2032) Table 157. North America γ-Aminobutyric Acid Receptor Agonists Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 158. North America γ-Aminobutyric Acid Receptor Agonists Sales by Country (2021-2026) & (K Units) Table 159. North America γ-Aminobutyric Acid Receptor Agonists Sales by Country (2027-2032) & (K Units) Table 160. North America γ-Aminobutyric Acid Receptor Agonists Revenue by Country (2021-2026) & (US$ Million) Table 161. North America γ-Aminobutyric Acid Receptor Agonists Revenue by Country (2027-2032) & (US$ Million) Table 162. Europe γ-Aminobutyric Acid Receptor Agonists Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 163. Europe γ-Aminobutyric Acid Receptor Agonists Sales by Country (2021-2026) & (K Units) Table 164. Europe γ-Aminobutyric Acid Receptor Agonists Sales by Country (2027-2032) & (K Units) Table 165. Europe γ-Aminobutyric Acid Receptor Agonists Revenue by Country (2021-2026) & (US$ Million) Table 166. Europe γ-Aminobutyric Acid Receptor Agonists Revenue by Country (2027-2032) & (US$ Million) Table 167. Asia Pacific γ-Aminobutyric Acid Receptor Agonists Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 168. Asia Pacific γ-Aminobutyric Acid Receptor Agonists Sales by Country (2021-2026) & (K Units) Table 169. Asia Pacific γ-Aminobutyric Acid Receptor Agonists Sales by Country (2027-2032) & (K Units) Table 170. Asia Pacific γ-Aminobutyric Acid Receptor Agonists Revenue by Country (2021-2026) & (US$ Million) Table 171. Asia Pacific γ-Aminobutyric Acid Receptor Agonists Revenue by Country (2027-2032) & (US$ Million) Table 172. South America γ-Aminobutyric Acid Receptor Agonists Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 173. South America γ-Aminobutyric Acid Receptor Agonists Sales by Country (2021-2026) & (K Units) Table 174. South America γ-Aminobutyric Acid Receptor Agonists Sales by Country (2027-2032) & (K Units) Table 175. South America γ-Aminobutyric Acid Receptor Agonists Revenue by Country (2021-2026) & (US$ Million) Table 176. South America γ-Aminobutyric Acid Receptor Agonists Revenue by Country (2027-2032) & (US$ Million) Table 177. Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 178. Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Sales by Country (2021-2026) & (K Units) Table 179. Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Sales by Country (2027-2032) & (K Units) Table 180. Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Revenue by Country (2021-2026) & (US$ Million) Table 181. Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Revenue by Country (2027-2032) & (US$ Million) Table 182. Global γ-Aminobutyric Acid Receptor Agonists Sales by Type (2021-2026) & (K Units) Table 183. Global γ-Aminobutyric Acid Receptor Agonists Sales by Type (2027-2032) & (K Units) Table 184. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Type (2021-2026) Table 185. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Type (2027-2032) Table 186. Global γ-Aminobutyric Acid Receptor Agonists Revenue by Type (2021-2026) & (US$ Million) Table 187. Global γ-Aminobutyric Acid Receptor Agonists Revenue by Type (2027-2032) & (US$ Million) Table 188. Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Type (2021-2026) Table 189. Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Type (2027-2032) Table 190. Global γ-Aminobutyric Acid Receptor Agonists Price by Type (2021-2026) & (US$/Unit) Table 191. Global γ-Aminobutyric Acid Receptor Agonists Price by Type (2027-2032) & (US$/Unit) Table 192. Global γ-Aminobutyric Acid Receptor Agonists Sales by Application (2021-2026) & (K Units) Table 193. Global γ-Aminobutyric Acid Receptor Agonists Sales by Application (2027-2032) & (K Units) Table 194. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Application (2021-2026) Table 195. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Application (2027-2032) Table 196. Global γ-Aminobutyric Acid Receptor Agonists Revenue by Application (2021-2026) & (US$ Million) Table 197. Global γ-Aminobutyric Acid Receptor Agonists Revenue by Application (2027-2032) & (US$ Million) Table 198. Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Application (2021-2026) Table 199. Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Application (2027-2032) Table 200. Global γ-Aminobutyric Acid Receptor Agonists Price by Application (2021-2026) & (US$/Unit) Table 201. Global γ-Aminobutyric Acid Receptor Agonists Price by Application (2027-2032) & (US$/Unit) Table 202. Key Raw Materials Table 203. Raw Materials Key Suppliers Table 204. γ-Aminobutyric Acid Receptor Agonists Distributors List Table 205. γ-Aminobutyric Acid Receptor Agonists Customers List Table 206. γ-Aminobutyric Acid Receptor Agonists Industry Trends Table 207. γ-Aminobutyric Acid Receptor Agonists Industry Drivers Table 208. γ-Aminobutyric Acid Receptor Agonists Industry Restraints Table 209. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. γ-Aminobutyric Acid Receptor Agonists Product Image Figure 5. Global γ-Aminobutyric Acid Receptor Agonists Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global γ-Aminobutyric Acid Receptor Agonists Market Size (2021-2032) & (US$ Million) Figure 7. Global γ-Aminobutyric Acid Receptor Agonists Sales (2021-2032) & (K Units) Figure 8. Global γ-Aminobutyric Acid Receptor Agonists Average Price (US$/Unit) & (2021-2032) Figure 9. GABAA Receptors Product Image Figure 10. GABAB Receptors Product Image Figure 11. GABAC Receptors Product Image Figure 12. Epilepsy Product Image Figure 13. Anxiety Product Image Figure 14. Neuropathic Pain Product Image Figure 15. Insomnia Product Image Figure 16. Other Product Image Figure 17. Global γ-Aminobutyric Acid Receptor Agonists Revenue Share by Manufacturers in 2025 Figure 18. Global Manufacturers of γ-Aminobutyric Acid Receptor Agonists, Manufacturing Sites & Headquarters Figure 19. Global Top 5 and 10 γ-Aminobutyric Acid Receptor Agonists Players Market Share by Revenue in 2025 Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global γ-Aminobutyric Acid Receptor Agonists Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 22. Global γ-Aminobutyric Acid Receptor Agonists Sales by Region in 2025 Figure 23. Global γ-Aminobutyric Acid Receptor Agonists Revenue by Region in 2025 Figure 24. North America γ-Aminobutyric Acid Receptor Agonists Market Size by Country in 2025 Figure 25. North America γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Country (2021-2032) Figure 26. North America γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Country (2021-2032) Figure 27. United States γ-Aminobutyric Acid Receptor Agonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Canada γ-Aminobutyric Acid Receptor Agonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe γ-Aminobutyric Acid Receptor Agonists Market Size by Country in 2025 Figure 30. Europe γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Country (2021-2032) Figure 31. Europe γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Country (2021-2032) Figure 32. Germany γ-Aminobutyric Acid Receptor Agonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France γ-Aminobutyric Acid Receptor Agonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. γ-Aminobutyric Acid Receptor Agonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy γ-Aminobutyric Acid Receptor Agonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands γ-Aminobutyric Acid Receptor Agonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Asia Pacific γ-Aminobutyric Acid Receptor Agonists Market Size by Country in 2025 Figure 38. Asia Pacific γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Country (2021-2032) Figure 39. Asia Pacific γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Country (2021-2032) Figure 40. China γ-Aminobutyric Acid Receptor Agonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Japan γ-Aminobutyric Acid Receptor Agonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. South Korea γ-Aminobutyric Acid Receptor Agonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. India γ-Aminobutyric Acid Receptor Agonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Australia γ-Aminobutyric Acid Receptor Agonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. China Taiwan γ-Aminobutyric Acid Receptor Agonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Southeast Asia γ-Aminobutyric Acid Receptor Agonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Southeast Asia γ-Aminobutyric Acid Receptor Agonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. South America γ-Aminobutyric Acid Receptor Agonists Market Size by Country in 2025 Figure 49. South America γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Country (2021-2032) Figure 50. South America γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Country (2021-2032) Figure 51. Mexico γ-Aminobutyric Acid Receptor Agonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Brazil γ-Aminobutyric Acid Receptor Agonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Argentina γ-Aminobutyric Acid Receptor Agonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Market Size by Country in 2025 Figure 55. Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Country (2021-2032) Figure 56. Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Country (2021-2032) Figure 57. Turkey γ-Aminobutyric Acid Receptor Agonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Saudi Arabia γ-Aminobutyric Acid Receptor Agonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. UAE γ-Aminobutyric Acid Receptor Agonists Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Type (2021-2032) Figure 61. Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Type (2021-2032) Figure 62. Global γ-Aminobutyric Acid Receptor Agonists Price (US$/Unit) by Type (2021-2032) Figure 63. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Application (2021-2032) Figure 64. Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Application (2021-2032) Figure 65. Global γ-Aminobutyric Acid Receptor Agonists Price (US$/Unit) by Application (2021-2032) Figure 66. γ-Aminobutyric Acid Receptor Agonists Value Chain Figure 67. γ-Aminobutyric Acid Receptor Agonists Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. γ-Aminobutyric Acid Receptor Agonists Industry Opportunities and Challenges

Scope & coverage.

Types
  • GABAA Receptors
  • GABAB Receptors
  • GABAC Receptors
Applications
  • Epilepsy
  • Anxiety
  • Neuropathic Pain
  • Insomnia
  • Other
Companies covered
  • Akorn
  • Apotex
  • CHEPLAPHARM
  • Hikma
  • Jazz Pharmaceuicals
  • Neurelis
  • SAGE Therapeutics
  • Sandoz
  • Torrent Pharma
  • Viatris
  • WG Critical Care
  • AstraZeneca
  • Changzhou Siyao Pharmaceutical
  • Fresenius Kabi
  • GSK
  • Sichuan HaiscoPharmaceuical
  • Huazhong Pharmaceutical
  • Pfizer
  • Roche
  • Mylan
  • Novartis
  • Sanofi
  • Shanghai Pharmaceuticals Holding
  • Sun Pharma
  • Teva
  • Takeda

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global γ-Aminobutyric Acid Receptor Agonists Market Size (2021-2032)
  4. 2.2.2 Global γ-Aminobutyric Acid Receptor Agonists Sales (2021-2032)
  5. 2.2.3 Global γ-Aminobutyric Acid Receptor Agonists Market Average Price (2021-2032)
  6. 2.3 γ-Aminobutyric Acid Receptor Agonists by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 GABAA Receptors
  9. 2.3.3 GABAB Receptors
  10. 2.3.4 GABAC Receptors
  11. 2.4 γ-Aminobutyric Acid Receptor Agonists by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Epilepsy
  14. 2.4.3 Anxiety
  15. 2.4.4 Neuropathic Pain
  16. 2.4.5 Insomnia
  17. 2.4.6 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global γ-Aminobutyric Acid Receptor Agonists Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global γ-Aminobutyric Acid Receptor Agonists Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global γ-Aminobutyric Acid Receptor Agonists Revenue of Manufacturers (2021-2026)
  4. 3.4 Global γ-Aminobutyric Acid Receptor Agonists Average Price by Manufacturers (2021-2026)
  5. 3.5 Global γ-Aminobutyric Acid Receptor Agonists Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of γ-Aminobutyric Acid Receptor Agonists, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of γ-Aminobutyric Acid Receptor Agonists, Product Type & Application
  8. 3.8 Global Manufacturers of γ-Aminobutyric Acid Receptor Agonists, Established Date
  9. 3.9 Global γ-Aminobutyric Acid Receptor Agonists Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Akorn
  2. 4.1.1 Akorn Company Information
  3. 4.1.2 Akorn Business Overview
  4. 4.1.3 Akorn γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Akorn γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  6. 4.1.5 Akorn Recent Developments
  7. 4.2 Apotex
  8. 4.2.1 Apotex Company Information
  9. 4.2.2 Apotex Business Overview
  10. 4.2.3 Apotex γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Apotex γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  12. 4.2.5 Apotex Recent Developments
  13. 4.3 CHEPLAPHARM
  14. 4.3.1 CHEPLAPHARM Company Information
  15. 4.3.2 CHEPLAPHARM Business Overview
  16. 4.3.3 CHEPLAPHARM γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 CHEPLAPHARM γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  18. 4.3.5 CHEPLAPHARM Recent Developments
  19. 4.4 Hikma
  20. 4.4.1 Hikma Company Information
  21. 4.4.2 Hikma Business Overview
  22. 4.4.3 Hikma γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Hikma γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  24. 4.4.5 Hikma Recent Developments
  25. 4.5 Jazz Pharmaceuicals
  26. 4.5.1 Jazz Pharmaceuicals Company Information
  27. 4.5.2 Jazz Pharmaceuicals Business Overview
  28. 4.5.3 Jazz Pharmaceuicals γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Jazz Pharmaceuicals γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  30. 4.5.5 Jazz Pharmaceuicals Recent Developments
  31. 4.6 Neurelis
  32. 4.6.1 Neurelis Company Information
  33. 4.6.2 Neurelis Business Overview
  34. 4.6.3 Neurelis γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Neurelis γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  36. 4.6.5 Neurelis Recent Developments
  37. 4.7 SAGE Therapeutics
  38. 4.7.1 SAGE Therapeutics Company Information
  39. 4.7.2 SAGE Therapeutics Business Overview
  40. 4.7.3 SAGE Therapeutics γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 SAGE Therapeutics γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  42. 4.7.5 SAGE Therapeutics Recent Developments
  43. 4.8 Sandoz
  44. 4.8.1 Sandoz Company Information
  45. 4.8.2 Sandoz Business Overview
  46. 4.8.3 Sandoz γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Sandoz γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  48. 4.8.5 Sandoz Recent Developments
  49. 4.9 Torrent Pharma
  50. 4.9.1 Torrent Pharma Company Information
  51. 4.9.2 Torrent Pharma Business Overview
  52. 4.9.3 Torrent Pharma γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Torrent Pharma γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  54. 4.9.5 Torrent Pharma Recent Developments
  55. 4.10 Viatris
  56. 4.10.1 Viatris Company Information
  57. 4.10.2 Viatris Business Overview
  58. 4.10.3 Viatris γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Viatris γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  60. 4.10.5 Viatris Recent Developments
  61. 4.11 WG Critical Care
  62. 4.11.1 WG Critical Care Company Information
  63. 4.11.2 WG Critical Care Business Overview
  64. 4.11.3 WG Critical Care γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 WG Critical Care γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  66. 4.11.5 WG Critical Care Recent Developments
  67. 4.12 AstraZeneca
  68. 4.12.1 AstraZeneca Company Information
  69. 4.12.2 AstraZeneca Business Overview
  70. 4.12.3 AstraZeneca γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 AstraZeneca γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  72. 4.12.5 AstraZeneca Recent Developments
  73. 4.13 Changzhou Siyao Pharmaceutical
  74. 4.13.1 Changzhou Siyao Pharmaceutical Company Information
  75. 4.13.2 Changzhou Siyao Pharmaceutical Business Overview
  76. 4.13.3 Changzhou Siyao Pharmaceutical γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Changzhou Siyao Pharmaceutical γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  78. 4.13.5 Changzhou Siyao Pharmaceutical Recent Developments
  79. 4.14 Fresenius Kabi
  80. 4.14.1 Fresenius Kabi Company Information
  81. 4.14.2 Fresenius Kabi Business Overview
  82. 4.14.3 Fresenius Kabi γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Fresenius Kabi γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  84. 4.14.5 Fresenius Kabi Recent Developments
  85. 4.15 GSK
  86. 4.15.1 GSK Company Information
  87. 4.15.2 GSK Business Overview
  88. 4.15.3 GSK γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 GSK γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  90. 4.15.5 GSK Recent Developments
  91. 4.16 Sichuan HaiscoPharmaceuical
  92. 4.16.1 Sichuan HaiscoPharmaceuical Company Information
  93. 4.16.2 Sichuan HaiscoPharmaceuical Business Overview
  94. 4.16.3 Sichuan HaiscoPharmaceuical γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Sichuan HaiscoPharmaceuical γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  96. 4.16.5 Sichuan HaiscoPharmaceuical Recent Developments
  97. 4.17 Huazhong Pharmaceutical
  98. 4.17.1 Huazhong Pharmaceutical Company Information
  99. 4.17.2 Huazhong Pharmaceutical Business Overview
  100. 4.17.3 Huazhong Pharmaceutical γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Huazhong Pharmaceutical γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  102. 4.17.5 Huazhong Pharmaceutical Recent Developments
  103. 4.18 Pfizer
  104. 4.18.1 Pfizer Company Information
  105. 4.18.2 Pfizer Business Overview
  106. 4.18.3 Pfizer γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Pfizer γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  108. 4.18.5 Pfizer Recent Developments
  109. 4.19 Roche
  110. 4.19.1 Roche Company Information
  111. 4.19.2 Roche Business Overview
  112. 4.19.3 Roche γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Roche γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  114. 4.19.5 Roche Recent Developments
  115. 4.20 Mylan
  116. 4.20.1 Mylan Company Information
  117. 4.20.2 Mylan Business Overview
  118. 4.20.3 Mylan γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Mylan γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  120. 4.20.5 Mylan Recent Developments
  121. 4.21 Novartis
  122. 4.21.1 Novartis Company Information
  123. 4.21.2 Novartis Business Overview
  124. 4.21.3 Novartis γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Novartis γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  126. 4.21.5 Novartis Recent Developments
  127. 4.22 Sanofi
  128. 4.22.1 Sanofi Company Information
  129. 4.22.2 Sanofi Business Overview
  130. 4.22.3 Sanofi γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  131. 4.22.4 Sanofi γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  132. 4.22.5 Sanofi Recent Developments
  133. 4.23 Shanghai Pharmaceuticals Holding
  134. 4.23.1 Shanghai Pharmaceuticals Holding Company Information
  135. 4.23.2 Shanghai Pharmaceuticals Holding Business Overview
  136. 4.23.3 Shanghai Pharmaceuticals Holding γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  137. 4.23.4 Shanghai Pharmaceuticals Holding γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  138. 4.23.5 Shanghai Pharmaceuticals Holding Recent Developments
  139. 4.24 Sun Pharma
  140. 4.24.1 Sun Pharma Company Information
  141. 4.24.2 Sun Pharma Business Overview
  142. 4.24.3 Sun Pharma γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  143. 4.24.4 Sun Pharma γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  144. 4.24.5 Sun Pharma Recent Developments
  145. 4.25 Teva
  146. 4.25.1 Teva Company Information
  147. 4.25.2 Teva Business Overview
  148. 4.25.3 Teva γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  149. 4.25.4 Teva γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  150. 4.25.5 Teva Recent Developments
  151. 4.26 Takeda
  152. 4.26.1 Takeda Company Information
  153. 4.26.2 Takeda Business Overview
  154. 4.26.3 Takeda γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2021-2026)
  155. 4.26.4 Takeda γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  156. 4.26.5 Takeda Recent Developments
5 Global γ-Aminobutyric Acid Receptor Agonists Market Scenario by Region
  1. 5.1 Global γ-Aminobutyric Acid Receptor Agonists Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global γ-Aminobutyric Acid Receptor Agonists Sales by Region: 2021-2032
  3. 5.2.1 Global γ-Aminobutyric Acid Receptor Agonists Sales by Region: 2021-2026
  4. 5.2.2 Global γ-Aminobutyric Acid Receptor Agonists Sales by Region: 2027-2032
  5. 5.3 Global γ-Aminobutyric Acid Receptor Agonists Revenue by Region: 2021-2032
  6. 5.3.1 Global γ-Aminobutyric Acid Receptor Agonists Revenue by Region: 2021-2026
  7. 5.3.2 Global γ-Aminobutyric Acid Receptor Agonists Revenue by Region: 2027-2032
  8. 5.4 North America γ-Aminobutyric Acid Receptor Agonists Market Facts & Figures by Country
  9. 5.4.1 North America γ-Aminobutyric Acid Receptor Agonists Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America γ-Aminobutyric Acid Receptor Agonists Sales by Country (2021-2032)
  11. 5.4.3 North America γ-Aminobutyric Acid Receptor Agonists Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe γ-Aminobutyric Acid Receptor Agonists Market Facts & Figures by Country
  15. 5.5.1 Europe γ-Aminobutyric Acid Receptor Agonists Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe γ-Aminobutyric Acid Receptor Agonists Sales by Country (2021-2032)
  17. 5.5.3 Europe γ-Aminobutyric Acid Receptor Agonists Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific γ-Aminobutyric Acid Receptor Agonists Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific γ-Aminobutyric Acid Receptor Agonists Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific γ-Aminobutyric Acid Receptor Agonists Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific γ-Aminobutyric Acid Receptor Agonists Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America γ-Aminobutyric Acid Receptor Agonists Market Facts & Figures by Country
  35. 5.7.1 South America γ-Aminobutyric Acid Receptor Agonists Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America γ-Aminobutyric Acid Receptor Agonists Sales by Country (2021-2032)
  37. 5.7.3 South America γ-Aminobutyric Acid Receptor Agonists Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global γ-Aminobutyric Acid Receptor Agonists Sales by Type (2021-2032)
  2. 6.1.1 Global γ-Aminobutyric Acid Receptor Agonists Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Type (2021-2032)
  4. 6.2 Global γ-Aminobutyric Acid Receptor Agonists Revenue by Type (2021-2032)
  5. 6.2.1 Global γ-Aminobutyric Acid Receptor Agonists Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Type (2021-2032)
  7. 6.3 Global γ-Aminobutyric Acid Receptor Agonists Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global γ-Aminobutyric Acid Receptor Agonists Sales by Application (2021-2032)
  2. 7.1.1 Global γ-Aminobutyric Acid Receptor Agonists Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Application (2021-2032)
  4. 7.2 Global γ-Aminobutyric Acid Receptor Agonists Revenue by Application (2021-2032)
  5. 7.2.1 Global γ-Aminobutyric Acid Receptor Agonists Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Application (2021-2032)
  7. 7.3 Global γ-Aminobutyric Acid Receptor Agonists Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 γ-Aminobutyric Acid Receptor Agonists Value Chain Analysis
  2. 8.1.1 γ-Aminobutyric Acid Receptor Agonists Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 γ-Aminobutyric Acid Receptor Agonists Production Mode & Process
  5. 8.2 γ-Aminobutyric Acid Receptor Agonists Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 γ-Aminobutyric Acid Receptor Agonists Distributors
  8. 8.2.3 γ-Aminobutyric Acid Receptor Agonists Customers
9 Global γ-Aminobutyric Acid Receptor Agonists Analyzing Market Dynamics
  1. 9.1 γ-Aminobutyric Acid Receptor Agonists Industry Trends
  2. 9.2 γ-Aminobutyric Acid Receptor Agonists Industry Drivers
  3. 9.3 γ-Aminobutyric Acid Receptor Agonists Industry Opportunities and Challenges
  4. 9.4 γ-Aminobutyric Acid Receptor Agonists Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst